Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, ...

* Intraday Charts now have option of 1 min duration also. This is available for NSE and BSE Indices & Stock charts only. * Please Note: The Intraday price data is close to real-time and doesn't ...

DOHA, Jan 9: The United Arab Emirates has added 19 individuals and legal entities, including UK-based education center Cambridge Education and Training Center, to the country’s terrorist list over ...

(Reuters) - Standard Chartered has formed a new entity in Luxembourg to offer crypto and digital asset custody services in the European Union, as the global lender looks to cash in on the growing ...

The objective of the Fund is to provide a combination of income and growth within a pre-determined risk profile. The Fund will invest in assets that generate higher income over assets that grow in ...

* Intraday Charts now have option of 1 min duration also. This is available for NSE and BSE Indices & Stock charts only. * Please Note: The Intraday price data is close to real-time and doesn't ...

CK-4015089 is under clinical development by Cytokinetics and currently in Phase I for Muscular Dystrophy. According to GlobalData, Phase I drugs for Muscular Dystrophy does not have sufficient ...

Stocks ended 2024 near record highs. Earnings growth accelerated. The market rally finally began to broaden. And despite a brief growth scare that spooked investors in late summer, the US economy ...

SOUTH SAN FRANCISCO, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on December 31, 2024 it granted stock options to purchase an aggregate of ...